Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Neutropenia and CYP3A[original query] |
---|
Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia. Blood 2004 Jan 103 (1): 67-72. Kishi Shinji, Yang Wenjian, Boureau Benoit, Morand Stanislas, Das Soma, Chen Peixian, Cook Edwin H, Rosner Gary L, Schuetz Erin, Pui Ching-Hon, Relling Mary |
Pharmacokinetics and toxicity of docetaxel: role of CYP3A, MDR1, and GST polymorphisms. Clinical pharmacology and therapeutics 2006 Jun 79 (6): 570-80. Tran A, Jullien V, Alexandre J, Rey E, Rabillon F, Girre V, Dieras V, Pons G, Goldwasser F, Tréluyer J |
PXR, CAR and HNF4alpha genotypes and their association with pharmacokinetics and pharmacodynamics of docetaxel and doxorubicin in Asian patients. The pharmacogenomics journal 2008 Apr 8 (2): 139-46. Hor S Y, Lee S C, Wong C I, Lim Y W, Lim R C, Wang L Z, Fan L, Guo J Y, Lee H S, Goh B C, Tan |
ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy. Cancer science 2015 Jan 106 (1): 86-93. Kim Hee-Jun, Im Seock-Ah, Keam Bhumsuk, Ham Hye Seon, Lee Kyung Hun, Kim Tae Yong, Kim Yu Jung, Oh Do-Youn, Kim Jee Hyun, Han Wonshik, Jang In-Jin, Kim Tae-You, Park In Ae, Noh Dong You |
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report. Frontiers in oncology 2022 2 11 809527. Powell Nicholas R, Shugg Tyler, Ly Reynold C, Albany Costantine, Radovich Milan, Schneider Bryan P, Skaar Todd |
- Page last reviewed:Feb 1, 2024
- Content source: